Patterns of concurrent chemotherapy selection in US patients undergoing trimodality therapy for muscle-invasive bladder cancer

被引：0
|
作者：
Callihan, Eryn [1 ]
Kuna, Elizabeth Molina [2 ]
Robin, Tyler P. [3 ]
Eule, Corbin J. [4 ]
Kim, Simon P. [5 ]
Flaig, Thomas W. [1 ]
机构：
[1] Univ Colorado, Canc Ctr, Anschutz Med Campus, Aurora, CO USA
[2] Univ Colorado, Populat Hlth Shared Resource, Canc Ctr, Aurora, CO USA
[3] Univ Colorado Anschutz Med Campus, Aurora, CO USA
[4] Univ Colorado, Div Med Oncol, Canc Ctr, Aurora, CO USA
[5] Univ Colorado Denver, Dept Urol Oncol, Denver, CO USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 4_SUPPL期
关键词：
261-566-148; 261-566-148-11342; 261-566-3248-2667; 283-183-138-226-11080; 6; 5; 3; 2; 176; 300; 62; 3590;
D O I：
10.1200/JCO.2024.42.4_suppl.554
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：554 / 554
页数：1
相关论文
共 50 条
  • [31] Subtyping muscle-invasive bladder cancer to assess clinical response to trimodality therapy.
    Efstathiou, Jason A.
    Gibb, Ewan
    Miyamoto, David Tomoaki
    Wu, Chin-Lee
    Drumm, Michael
    Lehrer, Jonathan
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [32] Prognostic Value of Complete Response in Patients with Muscle-invasive Bladder Cancer Undergoing Concurrent Chemoradiotherapy
    Wu, Chiao-En
    Lin, Yung-Chang
    Hong, Ji-Hong
    Chuang, Cheng-Keng
    Pang, See-Tong
    Liaw, Chuang-Chi
    ANTICANCER RESEARCH, 2013, 33 (06) : 2605 - 2610
  • [33] Re: Mutational Patterns in Chemotherapy Resistant Muscle-Invasive Bladder Cancer
    Chang, Sam S.
    JOURNAL OF UROLOGY, 2019, 202 (01): : 30 - 31
  • [34] Perioperative Chemotherapy for Muscle-Invasive Bladder Cancer
    Booth, Christopher M.
    Siemens, D. Robert
    Li, Gavin
    Peng, Yingwei
    Tannock, Ian F.
    Kong, Weidong
    Berman, David M.
    Mackillop, William J.
    CANCER, 2014, 120 (11) : 1630 - 1638
  • [35] Correlation of Circulating Tumor DNA (ctDNA) Dynamics with Clinical Response in Muscle-Invasive Bladder Cancer (MIBC) Patients Undergoing Trimodality Therapy (TMT)
    Epstein, I.
    Berg, S.
    Mantic, C.
    Mossanen, M.
    Saraf, A.
    Preston, M.
    Ravi, A.
    Carvalho, F. L.
    Clinton, T.
    Roberts, D.
    Peng, L. C.
    McGregor, B.
    Bellmunt, J.
    Berchuck, J.
    Mouw, K. W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E564 - E565
  • [36] Toward Biomarker-Informed Trimodality Therapy (TMT) Approaches for Muscle-Invasive Bladder Cancer
    Mouw, Kent W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (05): : 1417 - 1419
  • [37] Nomograms Predicting Response to Therapy and Outcomes After Bladder-Preserving Trimodality Therapy for Muscle-Invasive Bladder Cancer
    Coen, John J.
    Paly, Jonathan J.
    Niemierko, Andrzej
    Kaufman, Donald S.
    Heney, Niall M.
    Spiegel, Daphne Y.
    Efstathiou, Jason A.
    Zietman, Anthony L.
    Shipley, William U.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 86 (02): : 311 - 316
  • [38] Correlation of circulating tumor DNA (ctDNA) dynamics with clinical response in patients with muscle-invasive bladder cancer (MIBC) undergoing trimodality therapy (TMT)
    Epstein, Ilana B.
    Berg, Stephanie A.
    Mantia, Charlene
    Mossanen, Matthew
    Saraf, Anurag
    Preston, Mark A.
    Ravi, Arvind
    Carvalho, Filipe Lf
    Clinton, Timothy
    Roberts, Daniel Aaron
    Peng, Luke
    McGregor, Bradley Alexander
    Bellmunt, Joaquim
    Berchuck, Jacob E.
    Mouw, Kent William
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [39] MRI Follow-up of Patients Undergoing Concurrent Chemoradiotherapy in Muscle-invasive Bladder Cancer (MIBC)
    Anandadas, C. N.
    Swindell, R.
    Cowan, R. A.
    Carrington, B. M.
    Bonington, S. C.
    Choudhury, A.
    CLINICAL ONCOLOGY, 2011, 23 (03) : S28 - S28
  • [40] Combined intra-arterial chemotherapy and concurrent radiotherapy in compromised patients with muscle-invasive bladder cancer
    不详
    EUROPEAN UROLOGY SUPPLEMENTS, 2006, 5 (02) : 291 - 291
12345